Systemic Effects Related to the Use of 1% Cyclopentolate Hydrochloride Eye Drops in Refractometry in Cats

1 Rang HP, Dale MM, Ritter JM, Flower RJ, Henderson G: Cholinergic transmission. In: Pharmacology 5th edition (ed. Rang HP, Maureen Dale M). Churchill Livingstone: Philadelphia, 2003; 145-147. Search in Google Scholar

2 Clode A: Clinical pharmacology and therapeutics. In: Veterinary Ophthalmology 5th edition (Gelatt KN, Gilger CG, Kern TJ, eds.). John Wiley & Sons Inc: Iowa, 2013; 423-434. Search in Google Scholar

3 Glasser A: Accommodation. In: Adler’s Physiology of the Eye 11th edition (Levin LA, ed.) Elsevier Inc: Philadelphia: Elsevier Inc., 2011; 40-70. Search in Google Scholar

4 Ansari Mood M, Rajaei SM, Faghihi H, Ghiadi A: Effect of topical 1% cyclopentolate hydrochloride on tear production, intraocular pressure, and pupil size in healthy Turkman horses. J Equine Vet Sci 2019, 75:25-29. Search in Google Scholar

5 Ganesh S, Arora P, Sethi S, Gurung C: Cycloplegic Refraction in children: a complete audit cycle. Open J Ophthalmol 2015, 5:41-45. Search in Google Scholar

6 Kovalcuka L, Nikolajenko M: Changes in intraocular pressure, horizontal pupil diameter, and tear production during the use of topical 1% cyclopentolate in cats and rabbits. Open Vet J 2020, 10(1):59-67. Search in Google Scholar

7 Costa D, Leiva M, Coyo N, Laguna F, Ríos J, Peña Gimenez MT: Effect of topical 1% cyclopentolate hydrochloride on tear production, pupil size, and intraocular pressure in healthy Beagles. Vet Ophthalmol 2016, 19(6):449-453. Search in Google Scholar

8 Stadtbaumer K, Frommlet F, Nell B: Effects of mydriatics on intraocular pressure and pupil size in the normal feline eye. Vet Ophthalmol 2006, 9:233-237. Search in Google Scholar

9 Murphy CJ, Zadnik K, Mannis MJ: Myopia and refractive error in dogs. Invest Ophthalmol Vis Sci 1992, 33(8):2459-2463. Search in Google Scholar

10 Konrade KA, Hoffman AR, Ramey KL, Goldenberg RB, Lehenbauer TW: Refractive states of eyes and associations between ametropia and age, breed, and axial globe length in domestic cats. Am J Vet Res 2012, 73(2):279-284. Search in Google Scholar

11 Hancox J, Murdoch I, Parmar D: Changes in intraocular pressure following diagnostic mydriasis with cyclopentolate 1%. Eye 2002, 16:562-566. Search in Google Scholar

12 Hollingsworth SR, Canton DD, Buyukmihci NC, Farver TB: Effect of topically administered atropine on tear production in dogs. J Am Vet Med Assoc 1992, 200(10):1481-1484. Search in Google Scholar

13 Margadant DL, Kirkby K, Andrew SE, Gelatt KN: Effect of topical tropicamide on tear production as measured by Schirmer’s tear test in normal dogs and cats. Vet Ophthalmol 2003, 6(4):315-320. Search in Google Scholar

14 Ribeiro AP, Crivelaro RM, Teixeira PP, Trujillo DY, Guimarães PJ, Vicente WR, Martins Bda C, Laus JL: Effects of different mydriatics on intraocular pressure, pupil diameter, and ruminal and intestinal motility in healthy sheep. Vet Ophthalmol 2014, 17(6):397-402. Search in Google Scholar

15 Ortillés Á, Sanmartí J, Ríos J, Armengou L, Peña MT, Leiva M: Effects of topical 1% cyclopentolate hydrochloride on quantitative pupillometry measurements, tear production and intraocular pressure in healthy horses. Vet Ophthalmol 2020, 23(4):730–739. Search in Google Scholar

16 Salminen L: Review: systemic absorption of topically applied ocular drugs in humans. J Ocular Pharmacol 1990, 6:243-249. Search in Google Scholar

17 Rajeev A, Gupta G, Adhikari KM, Yadav AK, Sathyamoorthy M: Neurotoxic effects of topical cyclopentolate. Med J Armed Forces India 2010, 66(3):288-289. Search in Google Scholar

18 Bedirli N, Akgün F, Hondur A, Işık B: Suspected central anticholinergic syndrome related to cycloplegic eye drop in a premature baby. Balkan Med J 2012, 29(3):326-327. Search in Google Scholar

19 Bessonnat A, Vanore M: Effect of topical cyclopentolate alone or combined with phenylephrine in healthy horses. Vet Ophthalmol 2021, 24(6):582-590. Search in Google Scholar

20 Bhatia SS, Vidyashankar C, Sharma RK, Dubey AK: Systemic toxicity with cyclopentolate eye drops. Indian Pediatr 2000, 37(3):329-331. Search in Google Scholar

21 Hakim KT, Huupponen R, Salminen L, Iisalo E: Systemic absorption of ophthalmic cyclopentolate. Am J Ophthalmol 1989, 107:562-564. Search in Google Scholar

22 Bartlett JD: Mydriatics and cycloplegics. In: Ophthalmic Drug Facts (ed. Bartlett JD). Wolters Kluwer Health Inc.: St. Louis, 2004; 41-45. Search in Google Scholar

23 Isenberg SJ, Abrams C, Hyman, PE: Effects of cyclopentolate eyedrops on gastric secretory function in preterm infants. Ophthalmology 1985, 92:698-700. Search in Google Scholar

24 Kubai MA, Bentley E, Miller PE, et al. Ref ractive states of eyes and association between ametropia and breed in dogs. American Journal of Veterinary Research 2008; 69: 946-951. Search in Google Scholar

25 Calisaneller T, Ozdemir O, Sonmez E, Altinors N: Acute progressive midbrain hemorrhage after topical ocular cyclopentolate administration. Neurol India 2008, 56(1):88–89 Search in Google Scholar

26 Elibol O, Alçelik T, Yüksel N, Caglar Y: The influence of drop size of cyclopentolate, phenylephrine and tropicamide on pupil dilatation and systemic side effects in infants. Acta Ophthalmol Scand 1997, 75(2):178-180. Search in Google Scholar

27 Roy AK, Guillory J K: The kinetics and mechanism of the hydrolysis of cyclopentolate hydrochloride in alkaline solutions. Int J Pharmaceutics 1995, 120:169-170. Search in Google Scholar

28 Court MH: Feline drug metabolism and disposition pharmacokinetic evidence for species differences and molecular mechanisms. Vet Clin Small Anim 2013, 43:1039-1054. Search in Google Scholar

29 Baiza-Durán LM, González JR, Tornero Montaño R: Estudio clínico comparativo de la eficiencia de tres concentraciones de fenilefrina tópica oftálmica en población pediátrica. Revista Mexicana de Oftalmología 2005, 79:211-214. Search in Google Scholar

30 Alghamdi WM, Alrasheed SH, Nair V, Alluwimi MS. Effects of Cyclopentolate Hydrochloride Dosage on Anterior Segment Parameters in Young Adults (Measured with Pentacam). Clin Ophthalmol. 2021 Mar 1;15:891-898. Search in Google Scholar

31 Khoo BK, Koh A, Cheong P, Ho NK. Combination cyclopentolate and phenylephrine for mydriasis in premature infants with heavily pigmented irides. J Pediatr Ophthalmol Strabismus. 2000 Jan-Feb;37(1):15-20. doi: 10.3928/0191-3913-20000101-05. PMID: 10714690. Search in Google Scholar

32 Brenner RL: Pupillary dilatation with single-eyedrop mydriatic combinations. Am J Ophthalmol 1980, 90:271272. Search in Google Scholar

33 Hug T, Olitsky S: Dilation efficacy: Is 1% cyclopentolate enough? Optometry 2007, 78:119-121. Search in Google Scholar

34 Huupponen R, Kaila T, Saettone MF, Monti D, Ilsalo E, Salminen L, Oksala O. The effect of some macromolecular ionic complexes on the pharmacokinetics and – dynamics of ocular cyclopentolate in rabbits. J Ocul Pharmacol. 1992 Spring;8(1):59-67. Search in Google Scholar

35 Mirshahi A, Kohnen T: Acute psychotic reaction caused by topical cyclopentolate use for cycloplegic refraction before refraction surgery. J Cataract Refractive Surg 2003, 29:1026-1030. Search in Google Scholar